US5769897A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Synthetic bone
Assignee: Individual
•
Filing: 1994-02-28
•
Granted: 1998-06-23
•
Expires: 2014-02-28
Abstract
Abstract An artificial (namely synthetic) bone material is made up of a strength sustaining first component and of a biointegration promoting second component. The first component is made, for example of a bioceramic material providing a material strength, especially a compression strength, of at least 1000 N/cm 2 . The second component is made also of bioceramic material or even of bone tissue or it may contain bone tissue in combination with other biointegration enhancing components. Biointegration is greatly improved if the material of the second component comprises a specific surface of at least 1.5 m 2 /gram. The second component is incorporated in accessible voids such as open cells, pores, bores, holes and/or other cavities of the first component, whereby the first component forms a frame or matrix for the second component and imparts to the artificial bone the required strength prior to, during, and after implantation. The artificial bone material, due to its accessible voids in the first component and capillary ducts in the second component can receive one or more pharmaceutical substances. The material is formed to have a wedge shape for replacing or complementing a damaged or destroyed natural bone or a portion of a bone. The second component can fully or partly disintegrate upon completion of the implanting to promote penetration of freshly grown bone tissue into the first component.
Inventors
- 👤 Anton Harle
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:32
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/0095; A61F2/02; A61F2/28; A61F2/30; A61F2/44; A61F2/4455; A61F2/447; A61L; A61L27/00; A61L27/02; A61L27/40; A61L27/44; A61L27/48; A61L27/50; A61L27/58; A61F2/3094; A61F2/30965; A61F2/442; A61F2/46; A61F2/4603; A61F2/4611; A61F2002/2835; A61F2002/30001; A61F2002/30003; A61F2002/30004; A61F2002/30011; A61F2002/30032; A61F2002/3006; A61F2002/30062; A61F2002/30108; A61F2002/3011; A61F2002/30138; A61F2002/30153; A61F2002/30158; A61F2002/30199; A61F2002/30261; A61F2002/30266; A61F2002/3028; A61F2002/30316; A61F2002/30535; A61F2002/30581; A61F2002/30588; A61F2002/30593; A61F2002/30667; A61F2002/30677; A61F2/30767; A61F2/30771; A61F2002/30772; A61F2002/30777; A61F2002/30784; A61F2002/30785; A61F2002/30795; A61F2002/30807; A61F2002/30808; A61F2/30907; A61F2002/30909; A61F2002/30911; A61F2002/30968; A61F2210/00; A61F2210/0004; A61F2230/00; A61F2230/0002; A61F2230/0017; A61F2230/0019; A61F2230/0026; A61F2230/0063; A61F2230/0082; A61F2250/00; A61F2250/0014; A61F2250/0023; A61F2250/003; A61F2310/00; A61F2310/00005; A61F2310/00011; A61F2310/00023; A61F2310/00179; A61F2310/00185; A61F2310/00203; A61F2310/00293; A61L2430/00; A61L2430/02
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
142 words
A synthetic bone material comprising a first component for sustaining mechanical strength and a second component for enhancing biointegration, said first component containing at least one first biomaterial having a compression strength of at least 1000 N/cm 2 and a first biodegradability sufficiently small to sustain said compression strength, said second component containing at least one second biomaterial having a specific surface of at least 1.5 m 2 /gram and having a second biodegradability larger than said first biodegradability and sufficient to sustain said biointegration, said first component further having a body and a plurality of accessible voids in said body, said body and said voids together forming a tubular structure comprising a plurality of tubular channels each interconnecting a plurality of said accessible voids and said at least one second biomaterial at least partially filling said voids in said tubular structure.
Claim 2
Dependent Claim
142 words
A synthetic bone material comprising a first component for sustaining mechanical strength and a second component for enhancing biointegration, said first component containing at least one first biomaterial having a compression strength of at least 1000 N/cm 2 and a first biodegradability sufficiently small to sustain said compression strength, said second component containing at least one second biomaterial having a specific surface of at least 1.5 m 2 /gram and having a second biodegradability larger than said first biodegradability and sufficient to sustain said biointegration, said first component further having a body and a plurality of accessible voids in said body, said body and said voids together forming a tubular structure comprising a plurality of tubular channels each interconnecting a plurality of said accessible voids and said at least one second biomaterial at least partially filling said voids in said tubular structure.
Claim 3
Dependent Claim
16 words
The material of claim 1, wherein said at least one second biomaterial is natural bone tissue.
Claim 4
Dependent Claim
14 words
The material of claim 2, wherein said natural bone tissue is autologous bone tissue.
Claim 5
Dependent Claim
23 words
The material of claim 1, wherein said body is a cellular body, said cellular body and said voids together forming a honeycomb structure.
Claim 6
Dependent Claim
18 words
The material of claim 4, wherein said at least one channel is a passage in said honeycomb structure.
Claim 7
Dependent Claim
16 words
The material of claim 1, wherein said synthetic bone material is shaped as a formed body.
Claim 8
Dependent Claim
25 words
The material of claim 1, wherein said synthetic bone material has a texture which permits shaping into an anatomical configuration without destruction of said texture.
Claim 9
Dependent Claim
39 words
The material of claim 1, further comprising at least one substance selected from the group consisting of pharmaceuticals and radioisotopes and being at least substantially uniformly distributed in said synthetic bone material prior to implantation for release following implantation.
Claim 10
Dependent Claim
18 words
The material of claim 1, wherein one of said voids is adapted to receive particles of natural bone.
Claim 11
Dependent Claim
15 words
The material of claim 9, wherein said particles of natural bone are autologous bone particles.
Claim 12
Dependent Claim
37 words
The material of claim 1, wherein said synthetic bone material constitutes at least two formed bodies, said at least two formed bodies having complementary configurations permitting coupling of said at least two formed bodies to each other.
Claim 13
Dependent Claim
25 words
The material of claim 11 wherein, upon completed coupling to each other, said at least two formed bodies have the configuration of a natural bone.
Claim 14
Dependent Claim
31 words
The material of claim 1, wherein said at least one first biomaterial is a wedge-shaped body with a wedge angle alpha within a range of between about 2° and about 19°.
Claim 15
Dependent Claim
16 words
The material of claim 13, wherein said angle alpha is between about 2° and about 5°.
Claim 16
Dependent Claim
30 words
The material of claim 13, wherein said wedge-shaped body has a truncated end and a trapezoidal cross-section with a first end and a smaller second end at said truncated end.
Claim 17
Dependent Claim
83 words
The material of claim 1, wherein at least one of said first and second biomaterials is selected from the group consisting of bioceramic materials, carbon ceramics, aluminum oxide ceramics, glass ceramics, tricalciumphosphate ceramics (TCA), tetracalcium phosphate ceramics, hydroxylapatite ceramics (HA), polymethylmethacrylate, titanium, implantation alloys and biocompatible fiber composite materials, said at least one first biomaterial having voids therein in the range of 1 to 5 mm and said at least one second biomaterial having micropores within the range of 10 to 300 μm.
Claim 18
Dependent Claim
36 words
The material of claim 16, wherein said at least one first biomaterial is sintered tricalciuinphosphate (TCA) having said voids and said at least one second biomaterial is sintered hydroxylapatite (HA) at least partially occupying said voids.
Claim 19
Dependent Claim
36 words
The material of claim 16, wherein said at least one first biomaterial is sintered hydroxylapatite (HA) having said voids and said at least one second biomaterial is sintered tricalciumphosphate (TCA) at least partially occupying said voids.
Claim 20
Dependent Claim
47 words
The material of claim 1, wherein said at least one second biomaterial is a granular bioceramic material having a granule size in the range of between about 0.1 mm and 3 mm and defining interconnected pores having said specific surface of at least 1.5 m 2 /gram.
Claim 21
Dependent Claim
53 words
The material of claim 1, wherein said synthetic bone material has a first volume and said first component has a second volume taking up between about 5% and about 90% of said first volume, said second component having a third volume taking up between about 95% and about 10% of said first volume.
Claim 22
Dependent Claim
38 words
The material of claim 1, wherein said at least one first biomaterial is a macroporous bioceramic, said at least one second biomaterial constituting a microporous bioceramic having a sufficient number of open micropores to establish said specific surface.
Claim 23
Dependent Claim
18 words
The material of claim 21, wherein said second biodegradability is at least about 20 times said first biodegradability.
Claim 24
Dependent Claim
64 words
The material of claim 21, wherein said voids of said macroporous bioceramic have dimensions within the range of between about 1 mm and 5 mm and said micropores of said microporous bioceramic have dimensions within the range of between about 10 μm and about 300 μm, said microporous bioceramic further having capillary ducts interconnecting said micropores and having diameters of up to 20 μm.
Claim 25
Dependent Claim
42 words
The material of claim 21, wherein said accessible voids in said macroporous bioceramic have a total volume smaller than a porosity which would reduce the compression strength of said macroporous bioceramic below said compression strength of at least 1000 N/cm 2 .
References Cited (Backward Citations)
US2621145A
Cited
US2968593A
Cited
US3090094A
Cited
US3458397A
Cited
DE2242867A1
Cited
US4172128A
Cited
US4294753A
Cited
DE3106917A1
Cited
DE3435771A1
Cited
DE3445738A1
Cited
US4643735A
Cited
DE3615732A1
Cited
WO1987007827A1
Cited
WO1988001517A1
Cited
US4834757A
Cited
DE3903832A1
Cited
US4950296A
Cited
US5593409A
Cited
WO1990000037A1
Cited
US5609635A
Cited
EP0353476A2
Cited
US5458638A
Cited
US5263985A
Cited
US5281419A
Cited
US5425772A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-06-22 | 2001-12-22 | 2002-06-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-06-22 | 2005-12-22 | 2006-06-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-06-22 | 2009-12-22 | 2010-06-23 | $7700.00 | Window Closed / Lapsed |